Back
vTv Therapeutics, Inc. 10K Form
Buy
77
VTVT
vTv Therapeutics, Inc.
Last Price:
$37.18
Seasonality Move:
20.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | VTVT/vTv Therapeutics, Inc. Quarterly |
| 2023-08-11 | 10Q | VTVT/vTv Therapeutics, Inc. Quarterly |
| 2023-05-11 | 10Q | VTVT/vTv Therapeutics, Inc. Quarterly |
| 2022-11-10 | 10Q | VTVT/vTv Therapeutics, Inc. Quarterly |
| 2022-08-15 | 10Q | VTVT/vTv Therapeutics, Inc. Quarterly |
| 2022-05-12 | 10Q | VTVT/vTv Therapeutics, Inc. Quarterly |
Receive VTVT News And Ratings
See the #1 stock for the next 7 days that we like better than VTVT
VTVT Financial Statistics
Sales & Book Value
| Annual Sales: | $1M |
|---|---|
| Cash Flow: | $-4.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $17.91 |
| Price / Book: | 2.09 |
Profitability
| EPS (TTM): | -3.32310 |
|---|---|
| Net Income (TTM): | $-28.4M |
| Gross Margin: | $928K |
| Return on Equity: | -124.41% |
| Return on Assets: | -59.27% |
vTv Therapeutics, Inc. Earnings Forecast
Key vTv Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 12 years for VTVT is 91.25%.
-
The Selling, General & Administrative Expenses for VTVT have been equal to 1,342.28% of Gross Profit Margin.
-
The Research & Development expenses have been 1,126.55% of Revenue.
-
The Net Earning history of VTVT is -2,232.55% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 8 years.
vTv Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VTVT |
| CUSIP: | 918385 |
| Website: | vtvtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 9.79 |
| Quick Ratio: | 9.69 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VTVT Technical Analysis vs Fundamental Analysis
Buy
77
vTv Therapeutics, Inc. (VTVT)
is a Buy
Is vTv Therapeutics, Inc. a Buy or a Sell?
-
vTv Therapeutics, Inc. stock is rated a BuyThe current vTv Therapeutics, Inc. [VTVT] share price is $37.50. The Score for VTVT is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.